DTP Communications March, 2017 Formulary Addition and Criteria Emtricitabine-tenofovir alafenamide (Descovy™) February, 2017 Notice of Change Generic Antiretroviral Products August, 2015 Formulary Addition Dolutegravir-abacavir-lamivudine (Triumeq™) and Darunavir-cobicistat (Prezcobix™) June, 2014 Notice of Change to Forms Drug Treatment Program Enrolment and Prescription Request Forms April, 2014 Formulary Addition Dolutegravir (Tivicay™) May, 2013 Notice to prescribers and clients Drug Treatment Program Registry – Program Information Sheet Click here to link to the Drug Treatment Program Participant Information Sheet May, 2013 Formulary Addition Elvitegravir-cobicistat-emtricitabine-tenofovir DF (Stribild™) August, 2012 Formulary Addition Rilpivirine-emtricitabine-tenofovir DF (Complera™) & Rilpivirine (Edurant™) April, 2012 Formulary Addition Nevirapine Immediate Release (Viramune™ IR) and Nevirapine Extended Release (Viramune™ XR) Tablets Page1 Page2 Page3
